General MedicationsOPHTHALMICGeneric
BIMATOPROST
BIMATOPROST
Standard Dose
0.01%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary
Approval overview BIMATOPROST is listed in Drugs@FDA under application 203404 (ANDA).
Marketing status: None (Tentative Approval) Active ingredient BIMATOPROST Form and strength SOLUTION;OPHTHALMIC - 0.01% Sponsor APOTEX INC Submission history Latest submission status date: 2015-01-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview BIMATOPROST is listed in Drugs@FDA under application 203404 (ANDA). Marketing status: None (Tentative Approval) Active ingredient BIMATOPROST Form and strength SOLUTION;OPHTHALMIC - 0.01% Sponsor APOTEX INC Submission history Latest submission status date: 2015-01-07 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
Interaction Notes
- No interaction notes stored yet.